Objective
Exposure to inorganic arsenis from different sources is a major public health concern in many regions. In accordance with existing EU Guildelines for cancer risk assessment, and that is based on mechanism of action, the general aim of this project is to define "virtually safe " levels for arsenic based on elucidation of the basic process underlying the induction of genotoxic effects and cancer, taking into consideration differences in ethnical and individual susceptibility. While considering other mechanisms, like inhibition of p53 tumour suppresor gene function and somatic recombination and synergistic effects, one major task of this project is to demonstrate if arsenic inhibits DNA-repair in humans, a type of mechanism that implies a dose threshold for carcinogenic action. The dose-response relationship for in vivo induction of chromosomal aberrations will also be defined. A second major task is to explore the relation between detoxification (methylation ) patterns, genetic polymorphism and susceptibility to the chronic toxic action of arsenic. .
Fields of science
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
10691 Stockholm
Sweden
See on map
Participants (6)
08193 Bellaterra
See on map
37073 Goettingen
See on map
141 57 Huddinge
See on map
2300 RA Leiden
See on map
90 950 Lodz
See on map
76128 Karlsruhe
See on map